STAT6 and myocardial infarction: It can be concluded that IGF-1 is able to improve the prognosis after myocardial infarction by enabling bone marrow-derived neutrophils to develop an anti-inflammatory N2 phenotype through the atypical signaling pathway, the JAK2-STAT6 pathway [185].